Brief: India's Marksans Pharma Posts March-Qtr Profit
30/05/2018 08:29
May 30 (Reuters) - Marksans Pharma Ltd MARK.NS :
* MARCH QUARTER PROFIT 43.3 MILLION RUPEES VERSUS LOSS 24.4
MILLION RUPEES YEAR AGO
* MARCH QUARTER REVENUE FROM OPERATIONS 868.4 MILLION
RUPEES
VERSUS 539.5 MILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSE8sRSTT
Further company coverage: MARK.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg